Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Determination of IL-23 Pharmacokinetics by Highly Sensitive Accelerator Mass Spectrometry and Subsequent Modeling to Project IL-23 Suppression in Psoriasis Patients Treated with Anti-IL-23 Antibodies.

Zhang TT, Ma J, Durbin KR, Montavon T, Lacy SE, Jenkins GJ, Doktor S, Kalvass JC.

AAPS J. 2019 Jun 27;21(5):82. doi: 10.1208/s12248-019-0352-8.

PMID:
31250228
2.

Using echo state networks for classification: A case study in Parkinson's disease diagnosis.

Lacy SE, Smith SL, Lones MA.

Artif Intell Med. 2018 Mar;86:53-59. doi: 10.1016/j.artmed.2018.02.002. Epub 2018 Feb 21.

PMID:
29475631
3.

Targeting Anti-TGF-β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach.

McGaraughty S, Davis-Taber RA, Zhu CZ, Cole TB, Nikkel AL, Chhaya M, Doyle KJ, Olson LM, Preston GM, Grinnell CM, Salte KM, Giamis AM, Luo Y, Sun V, Goodearl AD, Gopalakrishnan M, Lacy SE.

J Am Soc Nephrol. 2017 Dec;28(12):3616-3626. doi: 10.1681/ASN.2017010013. Epub 2017 Aug 21.

4.

Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-Ig(TM)) molecule that specifically and potently neutralizes both IL-1α and IL-1β.

Lacy SE, Wu C, Ambrosi DJ, Hsieh CM, Bose S, Miller R, Conlon DM, Tarcsa E, Chari R, Ghayur T, Kamath RV.

MAbs. 2015;7(3):605-19. doi: 10.1080/19420862.2015.1026501.

5.

Americas Antibody Congress: September 21-23, 2009, Washington, D.C.

Lacy SE, Bond CJ, Benjamin D, Gerber HP, Dimitrov DS, Reichert JM.

MAbs. 2009 Nov-Dec;1(6):523-30. Epub 2009 Nov 1.

6.

The potency of erythropoietin-mimic antibodies correlates inversely with affinity.

Lacy SE, DeVries PJ, Xie N, Fung E, Lesniewski RR, Reilly EB.

J Immunol. 2008 Jul 15;181(2):1282-7.

7.

A potent erythropoietin-mimicking human antibody interacts through a novel binding site.

Liu Z, Stoll VS, Devries PJ, Jakob CG, Xie N, Simmer RL, Lacy SE, Egan DA, Harlan JE, Lesniewski RR, Reilly EB.

Blood. 2007 Oct 1;110(7):2408-13. Epub 2007 Jul 9.

8.

Identification of FLRT1, FLRT2, and FLRT3: a novel family of transmembrane leucine-rich repeat proteins.

Lacy SE, Bönnemann CG, Buzney EA, Kunkel LM.

Genomics. 1999 Dec 15;62(3):417-26.

PMID:
10644439
9.

Mortality from pancreatic and lymphopoietic cancer among workers in ethylene and propylene chlorohydrin production.

Olsen GW, Lacy SE, Bodner KM, Chau M, Arceneaux TG, Cartmill JB, Ramlow JM, Boswell JM.

Occup Environ Med. 1997 Aug;54(8):592-8.

10.

Half-century of cause-specific mortality experience of chemical manufacturing employees.

Olsen GW, Lacy SE, Cartmill JB, Kravat BA, Chamberlin SR, Spadacene NW, Lipps TE.

Am J Ind Med. 1994 Aug;26(2):203-19.

PMID:
7977396
11.

Retrospective cohort mortality study of workers with potential exposure to epichlorohydrin and allyl chloride.

Olsen GW, Lacy SE, Chamberlin SR, Albert DL, Arceneaux TG, Bullard LF, Stafford BA, Boswell JM.

Am J Ind Med. 1994 Feb;25(2):205-18.

PMID:
8147393
12.

A 5-year evaluation of a smoking cessation incentive program for chemical employees.

Olsen GW, Lacy SE, Sprafka JM, Arceneaux TG, Potts TA, Kravat BA, Gondek MR, Bond GG.

Prev Med. 1991 Nov;20(6):774-84.

PMID:
1766948
13.

A smoking cessation incentive program for chemical employees: design and evaluation.

Olsen GW, Shellenberger RJ, Lacy SE, Fishbeck WA, Bond GG.

Am J Prev Med. 1990 Jul-Aug;6(4):200-7.

PMID:
2223167
14.

Specific-heat measurements on superconducting Bi-Ca-Sr-Cu and Tl-Ca-Ba-Cu oxides: Absence of a linear term in the specific heat of Bi-Ca-Sr-Cu oxides.

Fisher RA, Kim S, Lacy SE, Phillips NE, Morris DE, Markelz AG, Wei JY, Ginley DS.

Phys Rev B Condens Matter. 1988 Dec 1;38(16):11942-11945. No abstract available.

PMID:
9946109
15.

Dow nurses make hearing conservation a reality.

Lacy SE.

Occup Health Saf. 1978 Jan-Feb;47(1):18-20. No abstract available.

PMID:
625381

Supplemental Content

Support Center